CHF is primarily diagnosed based on specific biomarkers, including brainnatriuretic peptide (BNP) and NT-prosomal BNP (NT-proBNP) levels [4, 5].Recently, identifying biomarkers that effectively screen CHF occurrence andmonitor disease development has gained special attention. The gene discussed is NPPB; the disease is congestive heart failure.